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ABSTRACT
Background and Objectives: Preconditioning gas by
humidification and warming the pneumoperitoneum im-
proves laparoscopic outcomes. This prevents peritoneal
desiccation and detrimental events related to traditional
cold-dry gas. Few comparisons have been done compar-
ing traditional cold-dry, heated-only, and humidified-
warmed carbon dioxide.
Methods: A prospective, controlled, randomized, double-
blind study of laparoscopic gastric banding included 113
patients and compared traditional dry-cold (n35) versus
dry-heated (n40), versus humidified-warm gas (n38).
Pain medications were standardized for all groups. End-
points were recovery room length of stay, pain location,
pain intensity, and total pain medications used postoper-
atively for up to 10 days.
Results: The humidified-warmed group had statistically
significant differences from the other 2 groups with im-
provement in all end points. The dry-heated group had
significantly more pain medication use and increased
shoulder and chest pain than the other 2 groups had.
Conclusion: Using warm-humidified gas for laparoscopic
gastric banding reduces shoulder pain, shortens recovery
room length of stay, and decreases pain medication re-
quirements for up to 10 days postoperatively. Dry-heated
gas may cause additional complications as is indicated by
the increase in pain medication use and pain intensity.




The acceptability of the laparoscopic adjustable gastric
banding (lap-band) procedure for obesity is well recog-
nized by both surgeons and patients for many reasons.
Laparoscopic surgical methods and variations have been
advanced to improve outcomes, reduce pain, shorten re-
covery, reduce complications, and improve quality of life.
The outcome of laparoscopic procedures has focused on
the nature of the disease process, patient selection, tech-
nical aspects of the procedure performed, and surgeon
skills without regard to the quality of gas used to create
the intraabdominal operating space. Changing the quality
of carbon dioxide (CO2) used to create and maintain
pneumoperitoneum by preconditioning the gas with hu-
midification and warming has been shown to improve
laparoscopic outcomes for Roux-en-Y gastric bypass pro-
cedures using the Insuflow gas conditioning technology.1
Although it would not be anticipated that the outcome of
a laparoscopic Roux-en-Y gastric bypass procedure com-
pared with a lap-band would be different, a clinical trial is
best to assert scientific findings. In addition, no study to
our knowledge has been done comparing different qual-
ities of gas used for laparoscopic gastric banding proce-
dures. The focus of this study is to evaluate in a prospec-
tive, randomized, controlled study postoperative
outcomes of pain, narcotic (opioid equivalent) use with
10-day follow-up of patients having laparoscopic gastric
banding comparing traditional dry-cold, dry-warmed, and
humidified-warmed gas.
MATERIALS AND METHODS
This study was performed at the Surgery Center of Rich-
ardson, Richardson, Texas, and was approved by its In-
stitutional Review Board. The authors performed all pro-
cedures and anesthesia instillation. The study was
compliant with all HIPAA regulations. Data regarding past
abdominal surgery, comorbidities, demographics, and an-
thropometry was obtained preoperatively. There was no
specific intervention or change in usual practices during
the study. Eligibility inclusion criteria included National
Institutes of Health criteria for bariatric surgery (including
BMI of 40 to 60 kg/m
2 or 35 to 39 kg/m
2 with associated
obesity-related comorbidities), acceptable operative risk
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SCIENTIFIC PAPER(including good cardiopulmonary function and overall
health status), and willingness to sign the informed con-
sent and follow the study protocol including the follow-up
assessments. Exclusion criteria included prior upper ab-
dominal surgery, except cholecystectomy, large abdomi-
nal ventral hernia, patients with hiatal hernia, minors, and
pregnant women. Informed written consent was obtained
from all patients. Randomization to 1 of the 3 groups was
done using a computerized software algorithm random-
number generator. The group assignment was unknown
by any of the investigators throughout the entire study
(surgery through 10-day follow-up). A total of 113
(n113) patients, 101 females and 12 males, were en-
rolled. The surgical procedure was the same for each
participant in all groups, being the pars flaccida approach
as previously described.2 One surgeon (RB) performed all
surgeries. The only difference was the use of dry-cold
(dc), dry-warmed (dw), or humidified-warmed (hw) gas
for the pneumoperitoneum. The study was done as a
prospective, controlled, randomized, double-blind study
of laparoscopic gastric banding comparing traditional dry-
cold (n35) versus dry-heated only [Stryker Heated Insuf-
flator Tubing (620–030-407)] (n40) vs. humidified-warm
[LEXION Medical, Insuflow
® gas conditioning system
(6198)] 35
o Centigrade/95% relative humidity (rh) (n38).
Pain medications were given based on pain and nausea
scores by using an 11-point verbal rating scale (VRS), with
0 being  none to 10  maximal, at 15-minute intervals
until discharge. VRS scores were standardized for all
groups based on their postoperative score, and analgesic
medication usage was converted to morphine equivalents.
Shoulder and abdominal pain were scored and tracked
separately. After discharge, patients self-administered
their pain medication, self-scored the level of pain, and
recorded this information for follow-up assessment. All
patients were in American Society of Anesthesiology
(ASA) classification I or II. Postoperative follow-up was
done by the surgeon and his staff. All participants com-
pleted treatment, and 10-day follow-up as allocated by
their study group. No data were excluded from analysis. A
sample size of 30 for each group was determined to be
necessary to have a high probability (power) of detecting
statistically significant and clinically important differences
of outcomes. Statistical assessment was done by testing for
differences in treatment group outcomes using parametric
and nonparametric tests for differences in means and
differences in variances. P values were generated from t
tests by using pooled (Lilliefors test) or separate (Wil-
coxon rank sum) variance. A P0.05 was considered
significant.
RESULTS
Ages ranged from 21 years to 61 years. BMI ranged from
35 to 55. Comorbidities included hypertension, diabetes,
dyslipidemia, sleep apnea, arthralgia, and gastric reflux.
No conversion from laparoscopy to laparotomy occurred
in any group. No intraoperative or postoperative compli-
cations occurred. All patients went home the same day of
surgery. No protocol violations occurred. The length of
the operation was similar for all groups, with the dry-cold
group ranging from 18 minutes to 52 minutes with a mean
of 31 minutes, the Insuflow
® group ranging 14 minutes to
48 minutes with a mean of 28 minutes, and the dry-heated
only group ranging from 19 minutes to 50 minutes with a
mean of 30 minutes. The total volume of gas used during
the procedures averaged 32.2 liters (L) for the humidified-
warm group, 28.2L for the dry-warm group, and 31.6L for
the dry-cold group. Recovery room time to discharge was
significantly shorter for the Insuflow group compared with
both other groups. The dry-cold group ranged from 62
minutes to 262 minutes with a mean of 153, the Insuflow
group ranged from 76 minutes to 200 minutes with a mean
of 138 minutes, and the dry-warm group ranged from 78
minutes to 270 minutes with a mean of 160 minutes
(Table 1).
Medication requirements for the Insuflow vs. dry-heated and
Insuflow vs. dry-cold groups was statistical significantly less,
P0.05 total morphine requirements. The total morphine
requirements for the Insuflow group was less than half
that for the dry-warm and dry-cold groups (Figures 1).
VRS pain score comparisons and statistical evaluations
comparing each group showed a statistically significant
reduction in pain scores for the Insuflow group (based on
VAS scoring). Humidified-warmed Insuflow
® produced
the lowest pain scores compared to dry-cold and dry-
warm and combined (P0.05). The dry-cold conventional
group had pain scores higher than the humidified-
warmed P0.05 and less than the dry-heated group. The
dry-heated Stryker group had the highest pain scores
compared with dry-cold and humidified-warmed P0.05.
DISCUSSION
Shoulder pain is a well-recognized common problem in
gastric banding and other laparoscopic procedures.3–5
Shoulder pain is so common that it is specifically men-
tioned on hospital and patient Web sites and included
in preoperative counseling materials given to patients
by physicians, clinics, and hospitals. Laparoscopic pain
is not improved by only heating the gas and is reported
to be made worse.6–8 Use of the Insuflow device sig-
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medication compared with conventional and warmed-
only CO2.9 Improvement in clinical outcomes using
Insuflow has also been shown for laparoscopic chole-
cystectomy and Roux-en-Y procedures.1,10,11 Many
studies1,9–15 show clinical improvements using humidi-
fied-warmed gas compared with traditional cold-dry
gas. Conditioning the gas to 95% rh and close to body
temperature (35
oC) mimics the normal condition of the
peritoneal cavity to maintain a physiologic homeostatic
environment preventing tissue desiccation that results
in an acute inflammatory response. The extreme dry-
ness of the gas initiates evaporation and desiccation,
causing peritoneal cell stress, releasing acute-phase re-
active inflammatory materials like interleukin-6 (IL-6)
and C-reactive protein (CRP) that are associated with
pain.16,17 Desiccation of the peritoneum during laparos-
copy causes adhesion formation that is reduced by
using humidified-warmed carbon dioxide.18
Improved well-being extending to 14 days when the Insu-
flow device is used has been reported compared with tradi-
tional gas in cholecystectomy and gynecology patients.9–11,15
Prevention of peritoneal desiccation as a cause of inflamma-
tion and trauma is the significant factor related to these
findings. The dryness of the gas in the unconditioned state
whether cold or warmed is 5000 times dryer than desert
conditions, because it has 200 parts per million of water
vapor or 0.0002% rh. This causes rapid loss of water content
of the peritoneal fluid resulting in laparoscopic hypothermia
due to evaporations and leads to peritoneal cell desiccation.
The stress of desiccation caused an inflammatory response
inducing release of interleukin-6, CRP, tumor necrosis factor-
alpha and other lymphokines, cytokines, and prostaglandins
indicative of cellular trauma.16 The results are increased re-
Table 1.












28 (14–48) 30 (19–50) 31 (18–52)
Volume of Gas (L) 32.3 28.2 31.6
Recovery Room Time
[mean min (range)]
138 (76–200) 160 (78–270) 153 (62–262) 0.05
Morphine Equivalent
(mg)
Recovery room 5.1 9.2 7.7 0.01
Day 1 4.5 6.4 6.7 0.05
Day 2 2.5 4.4 4.8 0.05
Day 3 1.5 3.2 3.4 0.05
Day 5 0.9 3.1 3.5 0.01
Day 7 0.2 1.9 1.7 0.01
Day 10 0.2 1.9 0.5 0.01
Postoperative
Shoulder Pain Score
3.8 7.3 6.7 0.01
Figure 1. Humidified-warm vs dry-cold vs dry-warm medication
requirements. The humidified-warm group used statistically sig-
nificantly less pain medication on all days. The dry-cold group
had significantly improved outcomes compared with the dry-
warm group.
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the dry-cold and dry-warm groups compared with the hu-
midified-warm group, and the warmed-only gas has higher
pain scores and more medication use than dry-cold gas
alone or compared with the dry-cold and humidified-warm
separately.
The cost of the Insuflow humidified warmed device is similar
to the Stryker dry-heated tubing. Both cost more than stan-
dard tubing. However, the standard tubing does nothing but
transport dry-cold gas from the insufflator to the patient. The
dry-heated tubing only changes the temperature of the gas.
The humidified-warmed device changes the extremely dry
gas to normal homeostatic levels and also warms the gas. As
this study demonstrates, there is a clinical difference in that
the humidified-warmed gas significantly changes and im-
proves outcomes. It was also noted that there is cost savings
with the humidified-warmed gas because of the reduced
recovery time and increasing utilization.
CONCLUSION
Changing the quality of the gas used for laparoscopy, mak-
ing it physiologically humidified and warmed to 95
oF and
95% relative humidity results in statistically significant im-
proved outcomes extending up to 10 days compared with
cold-dry or warm-dry gas. Dry heated-only gas may cause
additional complications due to the increase in pain medi-
cation and pain intensity. When dry gas, cold or warmed,
was compared, cold-dry gas was found to be less harmful to
patients. This comparative study of the quality of gas used for
the pneumoperitoneum showed that the combination of the
lap-band procedure and the Insuflow device offered the best
surgical outcome regarding pain, opioid use, and extended
follow-up. From the evidence found in this study, humidi-
fied-warmed gas for the pneumoperitoneum significantly
improved clinical outcomes by reducing postoperative pain,
reducing the use of morphine equivalents, and improving
quality of life immediately in the postoperative recovery with
improved early convalescence.
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